MedicalliansI had the chance to be introduced to China’s most prominent clinical specialist in next-generation oncology diagnostics by VVR Medical, as part of an all-encompassing China market entry mission.
Together with VVR Medical, we then initiated a first-in-the-world clinical proof of concept study for our new range of immune status-based in vitro diagnostics, whose results are changing the way immunotherapy is administered to lung cancer patients. VVR Medical team was instrumental in getting this study on track and ensuring its timely completion.
Then VVR Medical helped us formulate and implement our China strategy, including setting up Mainland China and Hong Kong legal entities, identifying the right distribution partner for our products, and supervising CRO work up to market authorization.
We strongly believe we are on the path to China success with VVR Medical’s support.